Partial Virological Response after 2 Years of Entecavir Therapy Increases the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Virus-Associated Cirrhosis

BACKGROUND/AIMS: The clinical significance of partial virological response (PVR) in patients undergoing antiviral therapy is not well known. This study investigated whether PVR after 2 years of entecavir (ETV) therapy is associated with hepatocellular carcinoma (HCC) development in cirrhotic patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Seung Kak, Yim, Hyung Joon, Kim, Jeong Han, Lee, Chan Uk, Yeon, Jong Eun, Suh, Sang Jun, Jung, Young Kul, Kim, Yun Soo, Kim, Ju Hyun, Kwon, Oh Sang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129658/
https://www.ncbi.nlm.nih.gov/pubmed/33115966
http://dx.doi.org/10.5009/gnl20074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129658/
https://www.ncbi.nlm.nih.gov/pubmed/33115966
http://dx.doi.org/10.5009/gnl20074

Ejemplares similares